Changes in Metabolite Ratios after Treatment with Rivastigmine in Alzheimer???s Disease

Clinical diagnosis of Alzheimer's disease

Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 27.8K citations · Full text

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.

B L Miller, Rex Moats, Truda Shonk et al. · Radiology · 1993 · 361 citations

Healthy Subjects, Proton Mr Spectroscopy, Elderly Patients +18

Probable Alzheimer disease: diagnosis with proton MR spectroscopy.

Truda Shonk, Rex Moats, P Gifford et al. · Radiology · 1995 · 300 citations

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD

Clifford R. Jack, M Słomkowski, S. Gracon et al. · Neurology · 2003 · 294 citations

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

Kousik Krishnan, H. Cecil Charles, P. Murali Doraiswamy et al. · American Journal of Psychiatry · 2003 · 286 citations